1. Home
  2. NVNO vs NCSM Comparison

NVNO vs NCSM Comparison

Compare NVNO & NCSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NVNO
  • NCSM
  • Stock Information
  • Founded
  • NVNO 1987
  • NCSM 2006
  • Country
  • NVNO United States
  • NCSM United States
  • Employees
  • NVNO N/A
  • NCSM N/A
  • Industry
  • NVNO Medical/Dental Instruments
  • NCSM Oilfield Services/Equipment
  • Sector
  • NVNO Health Care
  • NCSM Energy
  • Exchange
  • NVNO Nasdaq
  • NCSM Nasdaq
  • Market Cap
  • NVNO 71.0M
  • NCSM 76.3M
  • IPO Year
  • NVNO N/A
  • NCSM 2017
  • Fundamental
  • Price
  • NVNO $4.96
  • NCSM $30.21
  • Analyst Decision
  • NVNO
  • NCSM
  • Analyst Count
  • NVNO 0
  • NCSM 0
  • Target Price
  • NVNO N/A
  • NCSM N/A
  • AVG Volume (30 Days)
  • NVNO 137.7K
  • NCSM 6.7K
  • Earning Date
  • NVNO 08-04-2025
  • NCSM 08-04-2025
  • Dividend Yield
  • NVNO N/A
  • NCSM N/A
  • EPS Growth
  • NVNO N/A
  • NCSM N/A
  • EPS
  • NVNO N/A
  • NCSM 3.27
  • Revenue
  • NVNO N/A
  • NCSM $168,704,000.00
  • Revenue This Year
  • NVNO N/A
  • NCSM $7.17
  • Revenue Next Year
  • NVNO N/A
  • NCSM $5.44
  • P/E Ratio
  • NVNO N/A
  • NCSM $9.25
  • Revenue Growth
  • NVNO N/A
  • NCSM 18.16
  • 52 Week Low
  • NVNO $2.03
  • NCSM $16.66
  • 52 Week High
  • NVNO $5.92
  • NCSM $38.95
  • Technical
  • Relative Strength Index (RSI)
  • NVNO 62.60
  • NCSM 48.48
  • Support Level
  • NVNO $4.72
  • NCSM $29.65
  • Resistance Level
  • NVNO $5.13
  • NCSM $30.73
  • Average True Range (ATR)
  • NVNO 0.38
  • NCSM 0.68
  • MACD
  • NVNO 0.06
  • NCSM 0.04
  • Stochastic Oscillator
  • NVNO 61.85
  • NCSM 34.83

About NVNO enVVeno Medical Corporation

enVVeno Medical Corp is a late clinical-stage medical device company focused on advancing bioprosthetic (tissue-based) solutions to improve the standard of care for treating venous disease. The company's product, VenoValve, is a surgical replacement venous valve that is currently being evaluated in a U.S. pivotal study. The company is also developing a second product called enVVe, which is a non-surgical, transcatheter-based replacement venous valve. Both the products are designed to act as one-way valves to help assist in propelling blood up the veins of the leg, and back to the heart and lungs. The company has determined that it currently operates in a single segment, Medical Device development, located in a single geographic location, the United States.

About NCSM NCS Multistage Holdings Inc.

NCS Multistage Holdings Inc is a provider of engineered products and support services that facilitate the optimization of oil and natural gas well construction, well completions and field development strategies. NCS provides its products and services to exploration and production companies for use in onshore wells, predominantly wells that have been drilled with horizontal laterals in unconventional oil and natural gas formations. The company's offering is its fracturing systems products and services, which enable efficient pinpoint stimulation: the process of individually stimulating each entry point into a formation targeted by an oil or natural gas well. It sell products and services in North America and in selected international markets.

Share on Social Networks: